Home
About Acrux
Acrux History
Board of Directors
Management Team
Company Philosophy
Partnering with us
What We Do
Research & Development
Generic Product Development
Speciality Topical Drug Delivery
Product Pipeline
Products
Lidocaine and Prilocaine Cream, USP 2.5%/2.5%
LENZETTO
®
EVAMIST
®
Testosterone Topical Solution, 30 mg / 1.5 mL
Partnering With Us
Partnerships
Facilities & Capabilities
Investor Centre
Investor Fact Sheet
Corporate Governance
Announcements & Reports
Share Price Information
Shareholder Services
Email Alerts
Careers
Contact Us
Home
About Acrux
What We Do
Investor Centre
Careers
Contact Us
Investor Centre
Acrux
/
Investor Centre
/
Current Page
Email Alerts
Email Alerts
Enter your email address, then select the types of alert you’d like to subscribe to. Click ‘Submit’ to save your preferences.
If this is your first time subscribing, a confirmation email will be sent soon after you submit your preferences. Please open this email, and click the link listed inside to finalise your subscription to this service. You may return to this page at any time to modify your preferences.
Email
*
*
Alerts
*
ASX Announcement
Your request to subscribe to the following list(s) has been submitted:
None
You are currently not subscribed to the following list(s):
None
An email with user validation has been sent to
. To complete the process, please follow the instructions within the email.
Your subscription preferences have been updated. You are currently subscribed to:
None
You are currently not subscribed to the following list(s):
None
You may return to this screen at any time to update your subscription preferences.
Your subscription preferences have been updated. You are currently subscribed to:
None
You are currently not subscribed to the following list(s):
None
You may return to this screen at any time to update your subscription preferences.
Thanks for completing your subscription. You may return to this screen at any time to update your subscription preferences.
Select the types of alert you’d like to subscribe to, then click ‘Submit’ to save your preferences.
You may return to this page at any time to modify your preferences.
Email:
Alerts:
ASX Announcement
Investor Centre
Investor Fact Sheet
Corporate Governance
Announcements & Reports
Share Price Information
Shareholder Services
Email Alerts